The correlation between the quality of life using the World Health Organization Quality of Life Assessment questionnaire (WHOQOL- BREF) and Glycated Haemoglobin (HbA1c) in patients with diabetes

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ISRCTN

Registry ID

ISRCTN16494373

Enrollment

250

Registered

2018-06-05

Start date

2018-03-01

Completion date

Unknown

Last updated

2020-01-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes mellitus type 1 and type 2 Nutritional, Metabolic, Endocrine Diabetes mellitus

Interventions

The data is collected over 6-12 months. Quality of life is assessed using the WHOQOL-BREF questionnaire. The latest HbA1c is documented for each patient in their WHOQOL-BREF questionna

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Current inclusion criteria as of 24/08/2018: 1. Patients with diabetes both type 1 and type 2 2. Age range between 18 and 80 years old Previous exclusion criteria: 1. Patients with diabetes both type 1 and type 2 2. Age range between 18 and 65 years old

Exclusion criteria

Exclusion criteria: Current exclusion criteria as of 24/08/2018: 1. Gestational diabetes 2. Patients younger than 18 and older than 80 Previous exclusion criteria: 1. Gestational diabetes 2. Patients younger than 18 and older than 65

Design outcomes

Primary

Measure	Time frame
1. Quality of life, measured using the German version of WHO-BREF at 2 years 2. Glycemic control, measured using HbA1c value in the medical notes at 2 years	—

Secondary

Measure	Time frame
Type of diabetes treatment, measured using outpatient data and medical notes at 2 years	—

Countries

Austria

Contacts

Public ContactNawras Al-taie

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026